Charles River Laboratories International, Inc. (CRL) Stock Overview
Explore Charles River Laboratories International, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Charles River Laboratories International, Inc. (CRL)
Key Financials
Key Financials
Market Cap
13.1B
P/E Ratio
-56.41
EPS (TTM)
$9.90
ROE
-0.08%
CRL Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Charles River Laboratories International, Inc. (NYSE: CRL) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Charles River Laboratories International, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CRL on the NYSE shows an RSI of 47.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $162.68 for the NYSE listing.
Key metrics behind Charles River Laboratories International, Inc.'s NYSE-traded stock include a P/E ratio of -56.41 and a market capitalization of 13.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRL on the NYSE.